3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Multiple Myeloma
3
Lymphoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Mouth Neoplasms
1
Glioma
1
Fanconi Anemia
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
ruxolitinib
9
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Afatinib
×
1 year
×
Clear all
No trials found.